JW (Cayman) Therapeutics Co. Ltd (JWCTF)
USD 0.17
(0.0%)
USD 0.17
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -767.99 Million CNY | 9.23% |
| 2022 | -846.13 Million CNY | -20.48% |
| 2021 | -702.32 Million CNY | 57.79% |
| 2020 | -1.66 Billion CNY | -162.74% |
| 2019 | -633.25 Million CNY | -132.29% |
| 2018 | -272.61 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -16.53 Million USD | 0.0% |
| 2024 Q1 | -16.63 Million USD | 68.96% |
| 2023 Q4 | -53.6 Million USD | -101.97% |
| 2023 FY | -767.99 Million CNY | 9.23% |
| 2023 Q3 | -26.54 Million USD | 51.64% |
| 2023 Q2 | -54.88 Million USD | -98.17% |
| 2023 Q1 | -27.69 Million USD | 53.75% |
| 2022 Q4 | -59.87 Million USD | -104.39% |
| 2022 FY | -846.13 Million CNY | -20.48% |
| 2022 Q2 | -66.03 Million USD | 0.0% |
| 2022 Q3 | -29.29 Million USD | 55.63% |
| 2021 Q4 | -65.43 Million USD | 0.0% |
| 2021 Q2 | -43.37 Million USD | 0.0% |
| 2021 FY | -702.32 Million CNY | 57.79% |
| 2020 Q4 | -149.6 Million USD | 0.0% |
| 2020 FY | -1.66 Billion CNY | -162.74% |
| 2020 Q2 | -92.54 Million USD | 0.0% |
| 2019 FY | -633.25 Million CNY | -132.29% |
| 2019 Q4 | -39.34 Million USD | 0.0% |
| 2019 Q2 | -52.94 Million USD | 0.0% |
| 2018 FY | -272.61 Million CNY | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | -74.96 Million USD | -924.5% |
| Nanobac Pharmaceuticals, Incorporated | -6.57 Million USD | -11578.574% |
| SQZ Biotechnologies Company | -79.46 Million USD | -866.47% |
| Evofem Biosciences, Inc. | 52.97 Million USD | 1549.623% |
| Santhera Pharmaceuticals Holding AG | 65.13 Million USD | 1279.121% |
| Mesoblast Limited | -87.95 Million USD | -773.159% |
| Propanc Biopharma, Inc. | -1.82 Million USD | -42085.344% |
| Genus plc | 7.9 Million USD | 9821.468% |
| VioQuest Pharmaceuticals, Inc. | -10.89 Million USD | -6951.178% |
| CNBX Pharmaceuticals Inc. | -3.71 Million USD | -20599.395% |
| Marizyme, Inc. | -65.34 Million USD | -1075.26% |
| ContraFect Corporation | -65.15 Million USD | -1078.758% |
| Nymox Pharmaceutical Corporation | -8.84 Million USD | -8583.808% |
| PsyBio Therapeutics Corp. | -4.88 Million USD | -15618.095% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.72 Million USD | -44358.235% |
| Intellipharmaceutics International Inc. | -2.89 Million USD | -26452.261% |
| AXIM Biotechnologies, Inc. | -8.05 Million USD | -9428.862% |
| MultiCell Technologies, Inc. | -380.07 USD | -202066887.66% |
| Accustem Sciences Inc. | -3.74 Million USD | -20399.469% |
| RVL Pharmaceuticals plc | -51.69 Million USD | -1385.715% |
| EV Biologics, Inc. | -1.26 Million USD | -60508.902% |
| Q BioMed Inc. | -2.05 Million USD | -37325.009% |
| Emmaus Life Sciences, Inc. | -3.73 Million USD | -20473.158% |
| Neon Bloom, Inc. | -632.4 Thousand USD | -121340.149% |
| Mosaic ImmunoEngineering Inc. | -2.38 Million USD | -32156.948% |
| Biomind Labs Inc. | -1.21 Million USD | -63144.996% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Pharming Group N.V. | -10.54 Million USD | -7180.963% |
| Oncotelic Therapeutics, Inc. | -7.9 Million USD | -9617.664% |
| Skye Bioscience, Inc. | -37.64 Million USD | -1940.113% |
| Therapeutic Solutions International, Inc. | -2.16 Million USD | -35294.555% |
| THC Farmaceuticals, Inc. | -14.97 Thousand USD | -5128078.419% |
| Arch Therapeutics, Inc. | -6.98 Million USD | -10898.339% |
| IMV Inc. | -36.48 Million USD | -2004.924% |
| Acro Biomedical Co., Ltd. | -15.87 Million USD | -4738.854% |
| Curative Biotechnology, Inc. | -5.81 Million USD | -13102.039% |
| GB Sciences, Inc. | -1.36 Million USD | -56300.747% |
| Alpha Cognition Inc. | -13.77 Million USD | -5476.273% |
| HST Global, Inc. | -146.21 Thousand USD | -525169.133% |
| CSL Limited | 2.64 Billion USD | 129.069% |
| Halberd Corporation | -79.67 Thousand USD | -963798.79% |
| Enzolytics Inc. | -2.17 Million USD | -35180.444% |
| Resverlogix Corp. | -3.61 Million USD | -21174.127% |
| Affymax, Inc. | -14.42 Million USD | -5224.432% |
| SYBLEU INC | -180.3 Thousand USD | -425845.071% |
| Nuo Therapeutics, Inc. | -3.17 Million USD | -24116.033% |
| argenx SE | -295.05 Million USD | -160.291% |
| MetaStat, Inc. | - USD | Infinity% |
| Northwest Biotherapeutics, Inc. | -62.59 Million USD | -1126.85% |
| Enzon Pharmaceuticals, Inc. | 98 Thousand USD | 783769.388% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| RespireRx Pharmaceuticals Inc. | -3.97 Million USD | -19230.414% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | -3.02 Million USD | -25278.775% |
| AVAX Technologies, Inc. | -6.41 Million USD | -11874.402% |
| Zenith Capital Corp. | -10.59 Million USD | -7147.98% |
| Genscript Biotech Corporation | -95.47 Million USD | -704.378% |
| Ember Therapeutics, Inc. | -23.24 Thousand USD | -3304245.581% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -4.14 Million USD | -18424.068% |
| WPD Pharmaceuticals Inc. | -60.44 Thousand USD | -1270562.225% |
| American Oriental Bioengineering, Inc. | -59.72 Million USD | -1185.878% |
| Provectus Biopharmaceuticals, Inc. | -3.1 Million USD | -24659.943% |
| Adynxx, Inc. | - USD | Infinity% |
| Helix BioMedix, Inc. | -1.05 Million USD | -72622.969% |
| GlobeStar Therapeutics Corporation | -1.94 Million USD | -39299.584% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | -3.81 Million USD | -20009.872% |
| Cotinga Pharmaceuticals Inc. | -2 Million USD | -38201.843% |
| BioStem Technologies, Inc. | -8.48 Million USD | -8953.371% |
| ONE Bio Corp. | 8.67 Million USD | 8951.335% |
| Reve Technologies, Inc. | -441.36 Thousand USD | -173903.158% |
| Burzynski Research Institute, Inc. | -1.33 Million USD | -57409.224% |
| Wesana Health Holdings Inc. | -1.75 Million USD | -43666.167% |
| Agentix Corp. | -1.37 Million USD | -55786.323% |
| LadRx Corporation | 400.44 Thousand USD | 191886.596% |
| Cell Source, Inc. | -5.32 Million USD | -14332.727% |
| ProtoKinetix, Incorporated | -415.47 Thousand USD | -184745.925% |
| Regen BioPharma, Inc. | 1.02 Million USD | 75135.662% |
| Regen BioPharma, Inc. | 1.02 Million USD | 75135.662% |
| NovAccess Global Inc. | -4.76 Million USD | -16003.29% |
| Endonovo Therapeutics, Inc. | 6.92 Million USD | 11190.845% |
| Itoco Inc. | -1.86 Million USD | -40991.389% |
| Rasna Therapeutics, Inc. | -4.44 Million USD | -17187.337% |
| Pathfinder Cell Therapy, Inc. | -1.66 Million USD | -45915.339% |
| Kadimastem Ltd | -3.3 Million USD | -23120.55% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Institute of Biomedical Research Corp. | -273.4 Thousand USD | -280803.578% |
| CytoDyn Inc. | -49.84 Million USD | -1440.892% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -79.03 Thousand USD | -971640.918% |
| Mobile Lads Corp. | -2.26 Million USD | -33832.696% |
| NanoSphere Health Sciences Inc. | -228.12 Thousand USD | -336552.829% |
| Qrons Inc. | -789.34 Thousand USD | -97195.106% |
| Alseres Pharmaceuticals, Inc. | -941.52 Thousand USD | -81469.022% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| Nascent Biotech, Inc. | -2.08 Million USD | -36687.02% |
| Rebus Holdings, Inc. | -1.02 Million USD | -75193.725% |
| ImmunoCellular Therapeutics, Ltd. | -1.61 Million USD | -47520.66% |
| International Stem Cell Corporation | -131 Thousand USD | -586156.489% |
| Bioxytran, Inc. | -4.28 Million USD | -17843.823% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -54.27 Thousand USD | -1414986.969% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -2.53 Million USD | -30252.61% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -48.07 Million USD | -1497.595% |
| Adhera Therapeutics, Inc. | -2.11 Million USD | -36229.044% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -780.88 Thousand USD | -98249.185% |
| Innovation Pharmaceuticals Inc. | -3.16 Million USD | -24142.298% |
| Neutra Corp. | -233.46 Thousand USD | -328855.518% |
| Windtree Therapeutics, Inc. | -20.29 Million USD | -3684.91% |
| PureTech Health plc | -65.69 Million USD | -1068.997% |
| Coeptis Therapeutics, Inc. | -21.26 Million USD | -3511.288% |
| IXICO plc | -1.17 Million USD | -65094.907% |
| IntelGenx Technologies Corp. | -9.92 Million USD | -7636.436% |
| Gelesis Holdings, Inc. | -57.12 Million USD | -1244.343% |
| CSL Limited | 2.64 Billion USD | 129.069% |
| Cellectis S.A. | -103.17 Million USD | -644.371% |